Longaeva Partners L.P. Neuro Pace Inc Transaction History
Longaeva Partners L.P.
- $490 Billion
- Q2 2025
A detailed history of Longaeva Partners L.P. transactions in Neuro Pace Inc stock. As of the latest transaction made, Longaeva Partners L.P. holds 10,933 shares of NPCE stock, worth $117,529. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,933
Previous 99,985
89.07%
Holding current value
$117,529
Previous $1.23 Billion
90.09%
% of portfolio
0.02%
Previous 0.7%
Shares
2 transactions
Others Institutions Holding NPCE
# of Institutions
106Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$28.1 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$27.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$24.9 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$14.8 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$14.7 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $267M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...